Iatrogenic immunotherapy of lung cancer.
D000818:Animals; D000942:Antigens, Bacterial; D001424:Bacterial Infections / Q000276:immunology; D004653:Empyema; D004731:Endotoxins; D006801:Humans; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000276:immunology / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D011013:Pneumonectomy; D011135:Polysaccharides, Bacterial; D011183:Postoperative Complications; D011817:Rabbits; D012706:Serratia marcescens / Q000276:immunology; D014349:Trypanosoma cruzi / Q000276:immunology
D000942:Antigens, Bacterial; D004731:Endotoxins; D011135:Polysaccharides, Bacterial